Another Coronavirus Vaccine Is Proven To Be 94.5% Effective

Coronavirus Vaccine Trial (image: Reuters)

The Moderna vaccine is 94.5% effective against coronavirus, according to early data released Monday by the company.

This makes this vaccine the second vaccine in the United States to have a stunningly high success rate.

Moderna heard its results on a call Sunday afternoon with members of the Data Safety and Monitoring Board, an independent panel analyzing Moderna’s clinical trial data.

Vaccinations are expected to begin with high-risk groups and to be available for the rest of the population next spring.

Last week, Pfizer announced that early data show its vaccine is more than 90% effective against the disease.

In Moderna’s trial, 15,000 study participants were given a placebo, which is a shot of saline that has no effect.

Over several months, 90 of them developed Covid-19, with 11 developing severe forms of the disease.

Another 15,000 participants were given the vaccine, and only five of them developed Covid-19. None of the five became severely ill.

The company says its vaccine did not have any serious side effects. A small percentage of those who received it experienced symptoms such as body aches and headaches.

Moderna plans to apply to the US Food and Drug Administration for authorization of its vaccine soon after it accumulates more safety data later this month.

Initially, there won’t be enough vaccine for everyone. The highest priority groups, which include health care workers, the elderly, and people with underlying medical conditions, will get the vaccine first.

While the two vaccines appear to have very similar safety and efficacy profiles, Moderna’s vaccine has a significant practical advantage over Pfizer’s.

Pfizer’s vaccine has to be kept at minus 75 degrees Celsius. Doctors’ offices and pharmacies do not have freezers that go that low.

Moderna’s vaccine can be kept at minus 20 degrees Celsius. Other vaccines, such as the one against chickenpox, need to be kept at that temperature.

That means Moderna’s vaccine can be kept in a readily available freezer that is available in most doctors’ offices and pharmacies.

Another advantage of Moderna’s vaccine is that it can be kept for 30 days in the refrigerator, the company announced Monday. Pfizer’s vaccine can last only five days in the refrigerator.

Source: CNN||Kuulpeeps.com

Click on the comment box below and leave us your thoughts. Thank you

LEAVE A REPLY

Please enter your comment!
Please enter your name here